Procept Biorobotics CORP Form 4 insider transactions

Alaleh Nouri, EVP, CLO, CORP. SEC. of PROCEPT BioRobotics Corp, reported multiple transactions in common stock on August 13, 2026.

Larry L Wood, President, CEO and a Director of PROCEPT BioRobotics Corp, purchased 23,900 shares of common stock on August 7, 2026 for $20.85 per share.

Director Antal Rohit Desai reported a transaction involving the acquisition of 3,315 shares of common stock and 5,853 stock options in PROCEPT BioRobotics Corp.

Director Amy Dodrill of PROCEPT BioRobotics Corp. reported the acquisition of restricted stock units and stock options on June 9, 2026.

Mary Garrett, a Director at PROCEPT BioRobotics Corp, acquired restricted stock units and a stock option, as detailed in a recent SEC Form 4 filing.

Director Taylor C. Harris acquired 3,315 shares of common stock and was granted 5,853 stock options in PROCEPT BioRobotics Corp.

PROCEPT BioRobotics Corp reports a Form 4 filing detailing stock and option awards to Director Elisabeth Little.

Director Frederic H. Moll of Procept BioRobotics Corp. reported the acquisition of 3,315 shares of common stock and the grant of 5,853 stock options on June 9, 2026.

Director Thomas M. Prescott of Procept Biorobotics Corp. has acquired restricted stock units and a stock option, increasing his beneficial ownership.

Director Dan Puckett acquired restricted stock units and a stock option for PROCEPT BioRobotics Corp. shares.

EVP and CLO Alaleh Nouri sold 285 shares of PROCEPT BioRobotics to cover tax obligations related to RSU vesting.

EVP and CFO Kevin Waters sold 357 shares of PROCEPT BioRobotics common stock to satisfy tax withholding obligations.

PROCEPT BioRobotics EVP Alaleh Nouri sold common stock totaling 5,363 shares under a pre-arranged Rule 10b5-1 trading plan.

PROCEPT BioRobotics EVP, CLO, and Corporate Secretary Alaleh Nouri sold 304 shares of common stock to cover tax withholding obligations related to RSU vesting.

PROCEPT BioRobotics' EVP and CFO, Kevin Waters, sold 706 shares of common stock to cover tax withholding obligations related to RSU vesting.

Alaleh Nouri, EVP, CLO, and Corporate Secretary of PROCEPT BioRobotics Corp, reported the sale of 3,243 shares of common stock.

PROCEPT BioRobotics EVP, CLO, and Corporate Secretary Alaleh Nouri acquired 4,872 shares of common stock through the vesting of performance stock units.

PROCEPT BioRobotics Corp's EVP and CFO, Kevin Waters, was deemed to have earned 3,532 shares of common stock following the certification of performance criteria for previously granted performance stock units.

PROCEPT BioRobotics CEO Larry L. Wood received substantial equity awards, including 182,392 restricted stock units and options for 319,618 shares, alongside a forfeiture of 2,765 unvested RSUs.

PROCEPT BioRobotics Director Antal Rohit Desai exercised stock options to acquire 26,749 shares of common stock at $1.33 per share.

PROCEPT BioRobotics EVP, CLO, and Corporate Secretary Alaleh Nouri exercised 11,000 stock options at $4.52 per share, increasing direct common stock holdings.

A director at PROCEPT BioRobotics Corp, Frederic H. Moll, acquired 20,000 shares of common stock for approximately $785,138.

A director at PROCEPT BioRobotics Corp, Antal Rohit Desai, reported the sale of 75,000 shares of common stock through a Rule 10b5-1 trading plan, while also acquiring new restricted stock units and stock options.

PROCEPT BioRobotics Corp Director Frederic Moll reported the acquisition of 1,538 restricted stock units and 2,771 stock options on June 10, 2025, increasing his beneficial ownership in the company.

PROCEPT BioRobotics Corp. Director Elisabeth Sandoval was granted 1,538 restricted stock units and 2,771 stock options on June 10, 2025, as disclosed in a recent SEC Form 4 filing.

PROCEPT BioRobotics Corp. Director Larry L. Wood has increased his beneficial ownership in the company through the acquisition of Restricted Stock Units (RSUs) and stock options, aligning his interests further with shareholders.

PROCEPT BioRobotics Corp Director Taylor C. Harris has increased his beneficial ownership in the company through the acquisition of restricted stock units and stock options.

PROCEPT BioRobotics Corp. Director Mary Garrett was granted 1,538 restricted stock units and 2,771 stock options on June 10, 2025, as part of her compensation package.

PROCEPT BioRobotics Corp (PRCT) announced that Director Amy M. Dodrill was granted 1,538 restricted stock units (RSUs) and 2,771 stock options as part of her compensation.

PROCEPT BioRobotics Corp. Director Thomas M. Prescott reported the acquisition of 1,538 restricted stock units and 2,771 stock options on June 10, 2025, as part of his compensation.